FAST NEWS: MicroPort MedBot vascular surgical robot approved in China
The latest: Shanghai MicroPort MedBot (Group) Co. Ltd. (2522.HK) announced on Wednesday its R-ONE Vascular Interventional Surgical Robot jointly developed with France’s Robocath S.A.S has been approved by China’s National Medical…
2252.HK
Recent Articles
RELATED ARTICLES
-
Ubtech Robotics set to keep stumbling into the red
9880.HK
-
FAST NEWS: MicroPort MedBot places shares at significant discount
2252.HK
- CHINA BULLETIN: Manufacturing Déjà Vu
- CHINA BULLETIN: Services, Trade Send Positive Signals
- CHINA BULLETIN: Weak Inflation, Producer Price Data Hint at Flagging Rebound
- CHINA BULLETIN: Fiscal Revenue, Land Sales Fall in April
- CHINA BULLETIN: China-U.S. Rapprochement Continues with Xi-Biden Call, Yellen Visit
Discover hidden China stock gems in our weekly newsletter